Reversible neurotoxicity during interleukin-2 therapy for metastatic renal cell carcinoma

Eur J Cancer. 1995 Oct;31A(11):1895-7. doi: 10.1016/0959-8049(95)00297-v.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Brain / drug effects*
  • Carcinoma, Renal Cell / secondary*
  • Female
  • Humans
  • Interleukin-2 / adverse effects*
  • Kidney Neoplasms / pathology*
  • Magnetic Resonance Imaging
  • Middle Aged
  • Ovarian Neoplasms / secondary*

Substances

  • Interleukin-2